|
|
|
Insider
Information: |
Spiegelman Daniel K |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
148,092 |
|
Indirect Shares
|
6,673 |
|
|
Direct
Value |
$4,955,193 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
154,765 |
|
|
Total
Value |
$4,955,193 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
CV Therapeutics Inc |
CVTX |
SVP, CFO |
2009-04-09 |
67,489 |
2009-04-09 |
6,673 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2009-12-04 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2019-04-30 |
47,686 |
2012-05-29 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Myriad Genetics Inc |
MYGN |
Director |
2024-06-04 |
32,917 |
2020-05-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
182 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MYGN |
Myriad Genetics Inc |
Director |
|
2021-05-28 |
4 |
AS |
$28.99 |
$207,023 |
D/D |
(7,142) |
13,420 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2021-06-17 |
4 |
AS |
$30.52 |
$95,795 |
D/D |
(3,139) |
23,129 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2022-06-06 |
4 |
AS |
$19.25 |
$123,673 |
D/D |
(6,424) |
33,980 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2023-06-02 |
4 |
AS |
$23.01 |
$198,760 |
D/D |
(8,638) |
40,493 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2024-06-03 |
4 |
AS |
$22.04 |
$83,488 |
D/D |
(3,788) |
36,705 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2024-06-04 |
4 |
AS |
$22.05 |
$83,525 |
D/D |
(3,788) |
32,917 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2015-03-25 |
4 |
B |
$1.63 |
$16,271 |
D/D |
10,000 |
30,644 |
2.39 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2015-03-26 |
4 |
B |
$1.59 |
$15,856 |
D/D |
10,000 |
40,644 |
2.39 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2006-01-03 |
4 |
D |
$24.76 |
$1,263 |
D/D |
(51) |
886 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2006-12-05 |
4 |
D |
$12.84 |
$22,945 |
D/D |
(1,787) |
6,439 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2007-01-03 |
4 |
D |
$13.81 |
$60,557 |
D/D |
(4,385) |
11,786 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2007-11-09 |
4 |
D |
$10.12 |
$45,216 |
D/D |
(4,468) |
14,020 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2007-12-05 |
4 |
D |
$9.50 |
$16,977 |
D/D |
(1,787) |
17,233 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2007-12-11 |
4 |
D |
$9.40 |
$16,798 |
D/D |
(1,787) |
12,446 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2008-02-26 |
4 |
D |
$6.95 |
$13,928 |
D/D |
(2,004) |
9,953 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2008-12-09 |
4 |
D |
$9.51 |
$16,994 |
D/D |
(1,787) |
15,301 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2008-12-11 |
4 |
D |
$8.48 |
$15,154 |
D/D |
(1,787) |
18,514 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2009-02-25 |
4 |
D |
$15.58 |
$67,259 |
D/D |
(4,317) |
25,510 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2009-04-09 |
4 |
D |
$19.94 |
$118,643 |
D/D |
(5,950) |
67,489 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-12-04 |
4 |
D |
$6.86 |
$10,606 |
D/D |
(1,546) |
19,339 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-05-29 |
4 |
D |
$64.46 |
$269,701 |
D/D |
(4,184) |
42,016 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2013-06-09 |
4 |
D |
$1.86 |
$2,111 |
D/D |
(1,135) |
24,357 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2014-03-11 |
4 |
D |
$3.65 |
$17,659 |
D/D |
(4,838) |
38,871 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-05-15 |
4 |
D |
$57.44 |
$71,283 |
D/D |
(1,241) |
63,126 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-05-29 |
4 |
D |
$57.50 |
$218,040 |
D/D |
(3,792) |
59,334 |
0 |
- |
|
182 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|